Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors

American Journal of Human Genetics

Volumn 65, Issue 4, 1999, Pages 995-1006

  Varley, Jennifer M ^a   McGown, Gail ^d   Thorncroft, Mary ^d   James, Louise A ^d   Margison, Geoffrey P ^d   Forster, Gill ^d   Evans, D Gareth R ^b   Harris, Martin ^c   Kelsey, Anna M ^d   Birch, Jillian M ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL CORTEX TUMOR; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; HEREDITY; HETEROZYGOSITY LOSS; HUMAN; MALE; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0033365202     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302575     Document Type: Article

References (53)

1. Bardeesy N, Falkoff D, Petruzzi M-J, Nowak N, Zabel B, Adam M, Aguiar MC, et al (1994) Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7:91-97
2. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, Kovarik J, et al (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699-1703
3. Beroud C, Soussi T (1998) p53 gene mutations: software and database. Nucleic Acids Res 26:200-204
4. Birch JM, Blair V, Kelsey AM, Evans DGR, Harris M, Tricker KJ, Varley JM (1998) Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene 17:1061-1068
5. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, et al (1994a) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54:1298-1304
6. Birch JM, Heighway J, Teare MD, Kelsey AM, Hartley AL, Tricker KJ, Crowther D, et al (1994b) Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. Br J Cancer 70:1176-1181
7. Boyle JM, Greaves MJ, Camplejohn RS, Birch JM, Roberts SA, Varley JM (1999) Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations. Br J Cancer 79:1657-1664
8. Bremner R, Du DC, Connolly-Wilson MJ, Bridge P, Ahmad KF, Mostafchi H, Rushlow D, et al (1997) Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet 61:556-570
9. Campbell C, Quinn AG, Ro YS, Angus B, Rees JL (1993) p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasis of the skin. J Invest Dermatol 100:746-748
10. Cowell JK, Bia B (1998) A novel missense mutation in patients from a retinoblastoma pedigree showing only mild expression of the tumor phenotype. Oncogene 16:3211-3213
11. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, et al (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154
12. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS (1991) "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19:4008
13. Dryja TP, Rapaport J, McGee TL, Nork T, Schwartz TL (1993) Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 52:1122-1128
14. Felix CA, Hosler MR, Provisor D, Salhany K, Sexsmith EA, Slater DJ, Cheung N-KV, et al (1996) The p53 gene in pediatric therapy-related leukemia and myelodysplasia. Blood 87:4376-4381
15. Felix CA, Megonigal MD, Chervinsky DS, Leonard DGB, Tsuchida N, Kakati S, Block AMW, et al (1998) Association of germline p53 mutation with MLL. segmental jumping translocation in treatment-related leukemia. Blood 91:4451-4456
16. Felix CA, Strauss EA, D'Amico D, Tsokos M, Winter S, Mitsudomi T, Nau MM, et al (1993) A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 8:1203-1210
17. Frebourg T, Barbier N, Yan Y, Garber JE, Dreyfus M, Fraumeni J, Li FP, et al (1995) Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56:608-615
18. Giunta C, Youil R, Venter D, Chow CW, Somers G, Lafferty A, Kemper B, et al (1996) Rapid diagnosis of germline p53 mutation using the enzyme mismatch cleavage method. Diagn Mol Pathol 5:265-270
19. Grayson GH, Moore S, Schneider BG, Saldivar V, Hensel CH (1994) Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma. Am J Pediatr Hematol Oncol 16:341-347
20. Gutierrez MI, Bhatia KG, Barreiro C, Spangler G, Schvartzmann E, Muriel FS, Magrath IT (1994) A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors. Hum Mol Genet 3:2247-2248
21. Hamelin R, Barichard F, Henry I, Junien C, Thomas G (1994) Single base pair germ-line deletion in the p53 gene in a cancer predisposed family. Hum Genet 94:88-90
22. Harbour JW (1998) Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening. Ophthalmology 105:1442-1447
23. Hisada M, Garber JE, Fung CY, Fraumeni JF, Li FP (1998) Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 90:606-611
24. Horio Y, Suzuki H, Ueda R, Koshikawa T, Sugiura T, Ariyoshi Y, Shimokata K, et al (1994) Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 9:1231-1235
25. James LA, Kelsey A, Birch JM, Varley JM. Analysis of regions of gain and loss in childhood adrenocortical tumours by comparative genomic hybridisation. Br J Cancer (in press)
26. LeBihan C, Moutou C, Brugières L, Feunteun J, Bonaïti-Pellié C (1995) ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data. Genet Epidemiol 12:13-25
27. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358-5362
28. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B (1994) Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet 94:349-354
29. Lubbe J, von Ammon K, Watanabe K, Hegi ME, Kleihues P (1995) Familial brain tumour syndrome associated with a p53 germline deletion at codon 236. Brain Pathol 5:15-23
30. Malkhosyan S, Rampino N, Yamamoto H, Perucho M (1996) Frameshift mutator mutations. Nature 382:499-500
31. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238
32. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM (1992) Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 101:183-189
33. Moutou C, Le Bihan C, Chompret A, Poisson N, Brugières L, Bressac B, Feunteun J, et al (1996) Genetic transmission of susceptibility to cancer in families of children with soft tissue sarcomas. Cancer 78:1483-1491
34. Munn KE, Walker RA, Menasce L, Varley JM (1996) Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ. Br J Cancer 74:1578-1585
35. Onadim Z, Hogg A, Baird PN, Cowell JK (1992) Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci USA 89:6177-6181
36. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kenzler KW, Vogelstein B (1995) Microsatellite instability and mutations in the transforming growth factor b type II receptor gene in colorectal cancer. Cancer Res 55:5548-5550
37. Pivnick EK, Furman WL, Velagaleti GVN, Jenkins JJ, Chase NA, Ribiero RC (1998) Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation. J Med Genet 35:328-332
38. Ponder BA (1988) Gene losses in human tumours. Nature 335:400-402
39. Sameshima Y, Tsunematsu Y, Watanabe S, Tsukamoto T, Kawa-ha K, Hirata Y, Mizoguchi H, et al (1992) Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by screening patients with childhood adrenocortical carcinoma. J Natl Cancer Inst 84:703-707
40. Schubert EL, Strong LC, Hansen MF (1997) A splicing mutation in RB1 in low penetrance retinoblastoma. Hum Genet 100:557-563
41. Sedlacek Z, Kodet R, Kriz V, Seemanova E, Vodvarka P, Wilgenbus P, Mares J, et al (1998) Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild type p53 allele in only 50% of tumours. Br J Cancer 77:1034-1039
42. Soussi T, Caron de Fromentel C, May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945-952
43. Stolzenberg M-C, Brugières L, Gardes M, Dessarps-Freichey F, Chompret A, Bressac B, Lenoir G, et al (1994) Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni family. Oncogene 9:2799-2804
44. Strauss EA, Hosler MR, Herzog P, Salhany K, Louie R, Felix CA (1995) Complex replication error causes p53 mutation in a Li-Fraumeni family. Cancer Res 55:3237-3241
45. Varley JM, Chapman P, McGown G, Thorncroft M, White GRM, Greaves MJ, Scott D, et al (1998) Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Oncogene 16:3291-3298
46. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DGR, et al (1997a) Germline mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57:3245-3252
47. Varley JM, McGown G, Thorncroft M, Tricker KJ, Teare MD, Santibanez-Koref MF, Houlston RS, et al (1995) An extended Li Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. J Med Genet 32:946-950
48. Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KM, Evans DGR, et al (1997b) A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene. Oncogene 14:865-871
49. Varley JM, Thorncroft M, McGown G, Tricker K, Birch JM, Evans DGR (1996) A novel deletion within exon 6 of TP53 in a family with Li Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier. Cancer Genet Cytogenet 90:14-16
50. Vital A, Bringuier P-P, Huang H, Galli FS, Rivel J, Ansoborlo S, Cazauran J-M, et al (1998) Astrocytomas and choroid plexus rumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol 57:1061-1069
51. Wagner J, Portwine C, Rabin K, Leclerc J-M, Narod SA, Malkin D (1994) High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 86:1707-1710
52. Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L, Symonds G (1992) Germ-line splicing mutation of the p53 gene in a cancer-prone family. Cell Growth Differ 3:839-846
53. Wiedemann H-R (1983) Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129